Your session is about to expire
← Back to Search
RadProtect for Radiation Protection
Study Summary
This trial is testing a new drug, RadProtect, to see if it is safe and tolerated by healthy volunteers. The trial will be conducted at two clinical centers.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- You drink more than five alcoholic beverages every week.I am allergic to glutamate acid, polyethylene glycol, or ingredients in the test medicine.I have been on hormone replacement therapy in the last 3 months.I am using effective birth control and will continue for 60 days after the trial.I have a history of diabetes, blood pressure issues, stroke, seizures, heart, liver, kidney disease, active cancer, blood disorders, clotting problems, or HIV.I am a healthy volunteer aged 18-64.My BMI is between 18 and 30.I can understand and participate in phone and in-person visits for the study.I am of childbearing age and my pregnancy test was negative.
- Group 1: RadProtect®
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Who is eligible for enrollment in this research investigation?
"This clinical trial is seeking 27 participants, between ages 18 and 64, who are currently experiencing the effects of acute radiation syndrome. In addition to this parameter, candidates must also adhere to the following criteria: normal blood pressure (ranging from 120-140/60-80mmHg), be individuals of childbearing potential using adequate contraception during screening and treatment, provide written consent for the study, possess a body mass index ranging from 18-30kg/m2 with negative pregnancy test results at screening where applicable, demonstrate physiological examination and laboratory values within healthy parameters on CBC/differential tests as well as iron levels TIBC urinalysis EC"
Does this research endeavor include participants aged 45 and older?
"People aged between 18 and 64 are being recruited for this trial."
Has RadProtect® obtained the FDA's stamp of approval?
"The safety rating of the RadProtect® product is a 1, as it has yet to be tested extensively in clinical trials."
Are people currently being recruited to participate in this clinical trial?
"Clinicaltrials.gov records indicate this trial is not currently open for recruitment, despite having been posted on October 1st 2015 and updated 26 days later in the same month. Happily, 10 other trials are actively recruiting patients at present."
Share this study with friends
Copy Link
Messenger